Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 6:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2185–2208 of 3,979 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Mild Cognitive Impairment, Alzheimer Disease
Interventions: Virtual Music Therapy; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Vaginismus
Interventions: BOTOX; Biological
Lead sponsor: Plastic Surgery Professional Association; Other
Eligibility: 20 Years to 40 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Manchester, New Hampshire

Conditions: Alzheimer Disease, Dementia, Mild Cognitive Impairment, Cognitive Decline
Interventions: MindMate + Health Coaching, Health Education; Behavioral · Other
Lead sponsor: Neurotrack Technologies, Inc.; Industry
Eligibility: 45 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Conditions: Temporomandibular Joint Dysfunction, Pain, Arthrocentesis
Interventions: Hyaluronic acid, Corticosteroid, Lactated Ringers; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 5
States / cities: Los Angeles, California • Atlanta, Georgia • Cinncinati, Ohio + 2 more

Conditions: Chronic Ischemic Left Ventricular Dysfunction, Myocardial Infarction
Interventions: Autologous hMSCs, Autologous Human C-Kit CSCs II, Placebo, Biosense Webster MyoStar NOGA Injection Catheter System; Drug · Device
Lead sponsor: Joshua M Hare; Other
Eligibility: 21 Years to 89 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Indeterminate Colitis, Functional Abdominal Pain Syndrome, Functional Bowel Disorder, Esophageal Diseases, Gastroduodenal Disorder, Bowel Dysfunction, Gallbladder Diseases, Sphincter of Oddi Dysfunction, Anorectal Disorder
Interventions: Esophagogastroduodenoscopy (EGD) with biopsy, Colonoscopy w/ biopsy; Diagnostic Test
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 6 Years to 21 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Heart Failure, Congestive, Myocardial Infarction, Ventricular Dysfunction, Left
Interventions: Not listed
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 34,810 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 144
States / cities: Birmingham, Alabama • Mobile, Alabama • Mesa, Arizona + 121 more

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: d-cycloserine, glycine, placebo; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 54 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2004
U.S. locations: 4
States / cities: Los Angeles, California • Baltimore, Maryland • Glen Oaks, New York + 1 more

Conditions: Vulvodynia, Dyspareunia, Breast Cancer, Menopause
Interventions: Topical liquid lidocaine, Topical saline; Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Bradycardia, Sinus Node Dysfunction, Heart Block, Syncope, Cardiomyopathies, Ventricular Tachycardia, Heart Failure
Interventions: Physiologic pacing device implant; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 870 participants
Timeline: 2018 – 2021
U.S. locations: 26
States / cities: Huntsville, Alabama • Burlingame, California • San Diego, California + 22 more

Conditions: Mild Cognitive Impairment
Interventions: Active frontal, Active parietal, Sham; Device
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 40 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Erectile Dysfunction
Interventions: avanafil, Placebo; Drug
Lead sponsor: VIVUS LLC; Industry
Eligibility: 18 Years to 45 Years · Male only
Enrollment: 181 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 15
States / cities: Huntsville, Alabama • Los Angeles, California • San Diego, California + 12 more

Conditions: Congenital Heart Disease, Single Ventricle, Myocardial Fibrosis
Interventions: Not listed
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: MASH, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Interventions: Resmetirom; Drug
Lead sponsor: Madrigal Pharmaceuticals, Inc.; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: Active Transcranial Direct Current Stimulation (tDCS), Sham Transcranial Direct Current Stimulation (tDCS); Device
Lead sponsor: Minneapolis Veterans Affairs Medical Center; Federal
Eligibility: 60 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Multiple Sclerosis, Urinary Bladder, Overactive
Interventions: WeB, Standard pelvic floor physical therapy; Device · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Dysfunction; Endocrine, Effects of Chemotherapy, Premature Ovarian Failure
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Takotsubo Cardiomyopathy, Broken Heart Syndrome, Tako-tsubo Cardiomyopathy
Interventions: Not listed
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 110 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Chemotherapy-related Cognitive Impairment
Interventions: Low-Intensity Walking Intervention, Control Group Intervention; Behavioral
Lead sponsor: Ellis Medicine; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Schenectady, New York

Conditions: Mild Cognitive Impairment, Healthy Aging
Interventions: RFB, VSOP, IR; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 60 Years to 89 Years
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Hypopituitarism, Hypogonadism, Thyroid Dysfunction, Bone Diseases, Metabolic
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 2 Years to 24 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Aging
Interventions: Computerized Plasticity-Based Adaptive Cognitive Training, Educational DVDs; Other
Lead sponsor: Posit Science Corporation; Industry
Eligibility: 65 Years and older
Enrollment: 487 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cognitive Impairment
Interventions: Songwriting with licensed music therapist; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 7 Years to 17 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Dementia, Mild Cognitive Impairment
Interventions: Templated, clinician-facilitated intervention to align everyday living preferences assessment; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 55 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Belmont, Massachusetts

Search by objective public record fields.

Music Therapy for Patients With Alzheimer's Disease

Botox Injection for Treatment of Vaginismus

Reducing Dementia Risk With Digital Health Coaching

A Double Blind Study Comparing Hyaluronic Acid, Corticosteroid and Placebo During Arthrocentesis for Temporomandibular Joint (TMJ) Dysfunction

The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting

Adjunctive Treatment for Decreasing Symptoms of Schizophrenia

Therapy to Prevent Sexual Pain in Breast Cancer Survivors

Physiologic Pacing Registry

Investigating HD-tDCS in Improving Word Finding and Memory Retrieval in Individuals With MCI

Study Evaluating the Effects of Avanafil on Semen Parameters

Diffuse Myocardial Fibrosis in Fontan Patients

Study of Resmetirom in Children and Adolescents With MASH

tDCS and Cognitive Training for Mild Cognitive Impairment and Alzheimer's Dementia

Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study

Blood Spot Self-administered Test and Assay

Registry of Patients With Takotsubo Syndrome

Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)

Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients

Improvement in Memory With Plasticity-Based Adaptive Cognitive Training (IMPACT)

Family-Centered Songwriting in Pediatric Palliative Care

An Intervention to Reduce Discrepancy in Everyday Preferences